|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Winawer SJ: The multidisciplinary
management of gastrointestinal cancer. Colorectal cancer screening.
Best Pract Res Clin Gastroenterol. 21:1031–1048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baron JA, Cole BF, Sandler RS, Haile RW,
Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R,
Burke CA, et al: A randomized trial of aspirin to prevent
colorectal adenomas. N Engl J Med. 348:891–899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang CH, Liu LF, Shiu LY, Huang YS, Chang
LC and Kuo KW: Action of solamargine on TNFs and
cisplatin-resistant human lung cancer cells. Biochem Biophys Res
Commun. 322:751–758. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI
|
|
6
|
Yang H, Yin P, Shi Z, Ma Y, Zhao C, Zheng
J and Chen T: Sinomenine, a COX-2 inhibitor, induces cell cycle
arrest and inhibits growth of human colon carcinoma cells in vitro
and in vivo. Oncol Lett. 11:411–418. 2016.PubMed/NCBI
|
|
7
|
Kong LM, Feng T, Wang YY, Li XY, Ye ZN, An
T, Qing C, Luo XD and Li Y: Bisleuconothine A, a bisindole
alkaloid, inhibits colorectal cancer cell in vitro and in vivo
targeting Wnt signaling. Oncotarget. 7:10203–10214. 2016.PubMed/NCBI
|
|
8
|
Li W, Wen C, Bai H, Wang X, Zhang X, Huang
L, Yang X, Iwamoto A and Liu H: JNK signaling pathway is involved
in piperlongumine-mediated apoptosis in human colorectal cancer
HCT116 cells. Oncol Lett. 10:709–715. 2015.PubMed/NCBI
|
|
9
|
Sherr CJ: G1 phase progression: Cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ko LJ and Prives C: p53: Puzzle and
paradigm. Genes Dev. 10:1054–1072. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siliciano JD, Canman CE, Taya Y, Sakaguchi
K, Appella E and Kastan MB: DNA damage induces phosphorylation of
the amino terminus of p53. Genes Dev. 11:3471–3481. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rudolf E, Kralova V, Rudolf K and John S:
The role of p38 in irinotecan-induced DNA damage and apoptosis of
colon cancer cells. Mutat Res. 741–742. 27–34. 2013.
|
|
13
|
Arango D, Wilson AJ, Shi Q, Corner GA,
Arañes MJ, Nicholas C, Lesser M, Mariadason JM and Augenlicht LH:
Molecular mechanisms of action and prediction of response to
oxaliplatin in colorectal cancer cells. Br J Cancer. 91:1931–1946.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mansoor TA, Borralho PM, Luo X, Mulhovo S,
Rodrigues CM and Ferreira MJ: 6-Acetonyldihydrochelerythrine is a
potent inducer of apoptosis in HCT116 and SW620 colon cancer cells.
J Nat Prod. 77:1825–1830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yaffe PB, Coombs MR Power, Doucette CD,
Walsh M and Hoskin DW: Piperine, an alkaloid from black pepper,
inhibits growth of human colon cancer cells via G1 arrest and
apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog.
54:1070–1085. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mansoor TA, Borralho PM, Dewanjee S,
Mulhovo S, Rodrigues CM and Ferreira MJ: Monoterpene bisindole
alkaloids, from the African medicinal plant Tabernaemontana
elegans, induce apoptosis in HCT116 human colon carcinoma cells. J
Ethnopharmacol. 149:463–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdolahad M, Shashaani H, Janmaleki M and
Mohajerzadeh S: Silicon nanograss based impedance biosensor for
label free detection of rare metastatic cells among primary
cancerous colon cells, suitable for more accurate cancer staging.
Biosens Bioelectron. 59:151–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jordan A, Scholz R, Schüler J, Wust P and
Felix R: Arrhenius analysis of the thermal response of human
colonic adenocarcinoma cells in vitro using the multi-target,
single-hit and the linear-quadratic model. Int J Hyperthermia.
13:83–88. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XF, Liu XF, Yang YY, Liu AY, Zhang MY,
Bai XF, Gao H and Guo XG: Correlation study of Bcl-2, B7-H1, EGFR,
VEGF and colorectal cancer. Am J Cancer Res. 5:2277–2284.
2015.PubMed/NCBI
|
|
21
|
Koehler BC, Scherr AL, Lorenz S, Urbanik
T, Kautz N, Elssner C, Welte S, Bermejo JL, Jäger D and
Schulze-Bergkamen H: Beyond cell death-antiapoptotic Bcl-2 proteins
regulate migration and invasion of colorectal cancer cells in
vitro. PLoS One. 8:e764462013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hector S and Prehn JH: Apoptosis signaling
proteins as prognostic biomarkers in colorectal cancer: A review.
Biochim Biophys Acta. 1795:117–129. 2009.PubMed/NCBI
|
|
23
|
Rowinsky EK, Cazenave LA and Donehower RC:
Taxol: A novel investigational antimicrotubule agent. J Natl Cancer
Inst. 82:1247–1259. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hamilton G, Klameth L, Rath B and
Thalhammer T: Synergism of cyclin-dependent kinase inhibitors with
camptothecin derivatives in small cell lung cancer cell lines.
Molecules. 19:2077–2088. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harper JW: Cyclin dependent kinase
inhibitors. Cancer Surv. 29:91–107. 1997.PubMed/NCBI
|
